Incyte to Report Second Quarter Financial Results
July 11, 2019
WILMINGTON, Del.--(BUSINESSWIRE)--Jul. 11, 2019-- Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its second quarter 2019 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 2019.
The schedule for the press release and conference call/webcast is as follows:
• Q2 | 2019 | Press Release: | July 30, 2019 at 7:00 a.m. ET |
• Q2 | 2019 | Conference Call: | July 30, 2019 at 8:00 a.m. ET |
• Domestic Dial-In Number: | 877-407-3042 | ||
• International Dial-In Number: | 201-389-0864 | ||
• Conference ID Number: | 13692111 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is
877-660-6853and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13692111.
The live webcast with slides can be accessed at www.incyte.comunder For Investors, Events and Presentations and will be available for replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website atwww.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190711005001/en/
Source: Incyte Corporation
Investors
Michael Booth, DPhil +1 302 498 5914 mbooth@incyte.com
Media
Catalina Loveman +1 302 498 6171
cloveman@incyte.com
Attachments
- Original document
- Permalink
Disclaimer
Incyte Corporation published this content on 11 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 July 2019 12:02:07 UTC